Mutation of Influenza A Virus PA-X Decreases Pathogenicity in Chicken Embryos and Can Increase the Yield of Reassortant Candidate Vaccine Viruses

Overview

Journal J Virol

Publisher American Society for Microbiology

Date 2018 Nov 2

PMID 30381488

Citations 13

Authors

Saira Hussain

Matthew L Turnbull

Helen M Wise

Brett W Jagger

Philippa M Beard

Kristina Kovacikova

Jeffery K Taubenberger

Lonneke Vervelde

Othmar G Engelhardt

Paul Digard

Affiliations

Soon will be listed here.

Abstract

The PA-X protein of influenza A virus has roles in host cell shutoff and viral pathogenesis. While most strains are predicted to encode PA-X, strain-dependent variations in activity have been noted. We found that PA-X protein from the A/PR/8/34 (PR8) strain had significantly lower repressive activity against cellular gene expression than PA-X proteins from the avian strains A/turkey/England/50-92/91 (H5N1) (T/E) and A/chicken/Rostock/34 (H7N1). Loss of normal PA-X expression, either by mutation of the frameshift site or by truncating the X open reading frame (ORF), had little effect on the infectious virus titer of PR8 or PR8 7:1 reassortants with T/E segment 3 grown in embryonated hens' eggs. However, in both virus backgrounds, mutation of PA-X led to decreased embryo mortality and lower overall pathology, effects that were more pronounced in the PR8 strain than in the T/E reassortant, despite the low shutoff activity of the PR8 PA-X. Purified PA-X mutant virus particles displayed an increased ratio of hemagglutinin (HA) to nucleoprotein (NP) and M1 compared to values for their wild-type (WT) counterparts, suggesting altered virion composition. When the PA-X gene was mutated in the background of poorly growing PR8 6:2 vaccine reassortant analogues containing the HA and neuraminidase (NA) segments from H1N1 2009 pandemic viruses or from an avian H7N3 strain, HA yield increased up to 2-fold. This suggests that the PR8 PA-X protein may harbor a function unrelated to host cell shutoff and that disruption of the PA-X gene has the potential to improve the HA yield of vaccine viruses. Influenza A virus is a widespread pathogen that affects both humans and a variety of animal species, causing regular epidemics and sporadic pandemics, with major public health and economic consequences. A better understanding of virus biology is therefore important. The primary control measure is vaccination, which for humans mostly relies on antigens produced in eggs from PR8-based viruses bearing the glycoprotein genes of interest. However, not all reassortants replicate well enough to supply sufficient virus antigen for demand. The significance of our research lies in identifying that mutation of the PA-X gene in the PR8 strain of virus can improve antigen yield, potentially by decreasing the pathogenicity of the virus in embryonated eggs.

Citing Articles

PA-X protein of H1N1 subtype influenza virus disables the nasal mucosal dendritic cells for strengthening virulence.

Qin T, Chen Y, Huangfu D, Yin Y, Miao X, Yin Y Virulence. 2022; 13(1):1928-1942.

PMID: 36271710 PMC: 9629126. DOI: 10.1080/21505594.2022.2139474.

The Role of Viral RNA Degrading Factors in Shutoff of Host Gene Expression.

Gaucherand L, Gaglia M Annu Rev Virol. 2022; 9(1):213-238.

PMID: 35671567 PMC: 9530000. DOI: 10.1146/annurev-virology-100120-012345.

Emerging of H5N6 Subtype Influenza Virus with 129-Glycosylation Site on Hemagglutinin in Poultry in China Acquires Immune Pressure Adaption.

Xu N, Wu Y, Chen Y, Li Y, Yin Y, Chen S Microbiol Spectr. 2022; 10(3):e0253721.

PMID: 35446114 PMC: 9241720. DOI: 10.1128/spectrum.02537-21.

Chick fetal organ spheroids as a model to study development and disease.

Dakhel S, Davies W, Joseph J, Tomar T, Remeseiro S, Gunhaga L BMC Mol Cell Biol. 2021; 22(1):37.

PMID: 34225662 PMC: 8256237. DOI: 10.1186/s12860-021-00374-6.

PA-X is an avian virulence factor in H9N2 avian influenza virus.

Clements A, Peacock T, Sealy J, Lee H, Hussain S, Sadeyen J J Gen Virol. 2021; 102(3).

PMID: 33544070 PMC: 8515854. DOI: 10.1099/jgv.0.001531.

References

Medina J, Boukhebza H, de Saint Jean A, Sodoyer R, Legastelois I, Moste C . Optimization of influenza A vaccine virus by reverse genetic using chimeric HA and NA genes with an extended PR8 backbone. Vaccine. 2015; 33(35):4221-7. DOI: 10.1016/j.vaccine.2015.06.112. View

Hu J, Mo Y, Gao Z, Wang X, Gu M, Liang Y . PA-X-associated early alleviation of the acute lung injury contributes to the attenuation of a highly pathogenic H5N1 avian influenza virus in mice. Med Microbiol Immunol. 2016; 205(4):381-95. PMC: 7086737. DOI: 10.1007/s00430-016-0461-2. View

Klimov A, Balish A, Veguilla V, Sun H, Schiffer J, Lu X . Influenza virus titration, antigenic characterization, and serological methods for antibody detection. Methods Mol Biol. 2012; 865:25-51. DOI: 10.1007/978-1-61779-621-0_3. View

Barman S, Krylov P, Turner J, Franks J, Webster R, Husain M . Manipulation of neuraminidase packaging signals and hemagglutinin residues improves the growth of A/Anhui/1/2013 (H7N9) influenza vaccine virus yield in eggs. Vaccine. 2017; 35(10):1424-1430. DOI: 10.1016/j.vaccine.2017.01.061. View

Klenk H, Garten W, Matrosovich M . Molecular mechanisms of interspecies transmission and pathogenicity of influenza viruses: Lessons from the 2009 pandemic. Bioessays. 2011; 33(3):180-8. DOI: 10.1002/bies.201000118. View

Hu J, Mo Y, Wang X, Gu M, Hu Z, Zhong L . PA-X decreases the pathogenicity of highly pathogenic H5N1 influenza A virus in avian species by inhibiting virus replication and host response. J Virol. 2015; 89(8):4126-42. PMC: 4442343. DOI: 10.1128/JVI.02132-14. View

Xu G, Zhang X, Liu Q, Bing G, Hu Z, Sun H . PA-X protein contributes to virulence of triple-reassortant H1N2 influenza virus by suppressing early immune responses in swine. Virology. 2017; 508:45-53. DOI: 10.1016/j.virol.2017.05.002. View

Brookes D, Miah S, Lackenby A, Hartgroves L, Barclay W . Pandemic H1N1 2009 influenza virus with the H275Y oseltamivir resistance neuraminidase mutation shows a small compromise in enzyme activity and viral fitness. J Antimicrob Chemother. 2010; 66(3):466-70. PMC: 3037153. DOI: 10.1093/jac/dkq486. View

Plant E, Liu T, Xie H, Ye Z . Mutations to A/Puerto Rico/8/34 PB1 gene improves seasonal reassortant influenza A virus growth kinetics. Vaccine. 2012; 31(1):207-12. DOI: 10.1016/j.vaccine.2012.10.060. View

10.

de Wit E, Spronken M, Bestebroer T, Rimmelzwaan G, Osterhaus A, Fouchier R . Efficient generation and growth of influenza virus A/PR/8/34 from eight cDNA fragments. Virus Res. 2004; 103(1-2):155-61. DOI: 10.1016/j.virusres.2004.02.028. View

11.

Hoffmann E, Neumann G, Kawaoka Y, HOBOM G, Webster R . A DNA transfection system for generation of influenza A virus from eight plasmids. Proc Natl Acad Sci U S A. 2000; 97(11):6108-13. PMC: 18566. DOI: 10.1073/pnas.100133697. View

12.

Khaperskyy D, McCormick C . Timing Is Everything: Coordinated Control of Host Shutoff by Influenza A Virus NS1 and PA-X Proteins. J Virol. 2015; 89(13):6528-31. PMC: 4468473. DOI: 10.1128/JVI.00386-15. View

13.

Hayashi T, MacDonald L, Takimoto T . Influenza A Virus Protein PA-X Contributes to Viral Growth and Suppression of the Host Antiviral and Immune Responses. J Virol. 2015; 89(12):6442-52. PMC: 4474289. DOI: 10.1128/JVI.00319-15. View

14.

Wanitchang A, Kramyu J, Jongkaewwattana A . Enhancement of reverse genetics-derived swine-origin H1N1 influenza virus seed vaccine growth by inclusion of indigenous polymerase PB1 protein. Virus Res. 2009; 147(1):145-8. DOI: 10.1016/j.virusres.2009.10.010. View

15.

Gao H, Xu G, Sun Y, Qi L, Wang J, Kong W . PA-X is a virulence factor in avian H9N2 influenza virus. J Gen Virol. 2015; 96(9):2587-2594. DOI: 10.1099/jgv.0.000232. View

16.

Harvey R, Johnson R, MacLellan-Gibson K, Robertson J, Engelhardt O . A promoter mutation in the haemagglutinin segment of influenza A virus generates an effective candidate live attenuated vaccine. Influenza Other Respir Viruses. 2014; 8(6):605-12. PMC: 4262274. DOI: 10.1111/irv.12274. View

17.

Benton D, Martin S, Wharton S, McCauley J . Biophysical measurement of the balance of influenza a hemagglutinin and neuraminidase activities. J Biol Chem. 2015; 290(10):6516-21. PMC: 4358285. DOI: 10.1074/jbc.M114.622308. View

18.

Harvey R, Nicolson C, Johnson R, Guilfoyle K, Major D, Robertson J . Improved haemagglutinin antigen content in H5N1 candidate vaccine viruses with chimeric haemagglutinin molecules. Vaccine. 2010; 28(50):8008-14. DOI: 10.1016/j.vaccine.2010.09.006. View

19.

Abernathy E, Clyde K, Yeasmin R, Krug L, Burlingame A, Coscoy L . Gammaherpesviral gene expression and virion composition are broadly controlled by accelerated mRNA degradation. PLoS Pathog. 2014; 10(1):e1003882. PMC: 3894220. DOI: 10.1371/journal.ppat.1003882. View

20.

Gao H, Sun H, Hu J, Qi L, Wang J, Xiong X . Twenty amino acids at the C-terminus of PA-X are associated with increased influenza A virus replication and pathogenicity. J Gen Virol. 2015; 96(8):2036-2049. PMC: 4681059. DOI: 10.1099/vir.0.000143. View